A recent DGIST study shows somatostatin overexpression reduces inflammation and amyloid β in mice, suggesting repurposing existing drugs like octreotide could accelerate Alzheimer’s therapy and...
Recent research reveals APOE4 increases hippocampal neuron excitability before Alzheimer’s symptoms, offering early detection via interictal spikes and potential interventions targeting Nell2 pr...
Recent research shows probiotics and fecal microbiota transplantation reduce neuroinflammation via the gut-brain axis, offering promising therapies for neurodegenerative diseases with clinical trials ...
A new study reveals ANKRD1 gene therapy improves memory in aged mice by enhancing neurogenesis, signaling potential for anti-aging treatments targeting brain health. ANKRD1 gene therapy boosts memory ...
A groundbreaking study reveals that depleting the gut microbiome in aged mice improves memory and reduces brain inflammation, highlighting the gut-brain axis as a target for non-invasive aging interve...
Recent research confirms TDP-43 aggregation in vascular dementia, with advancements in biomarkers and therapies highlighting potential for early intervention and personalized prevention. New studies r...
The cGAS-STING pathway, crucial for innate immunity, drives harmful neuroinflammation in aging and Alzheimer’s, with recent studies highlighting therapeutic challenges and biomarker potential fo...
A July 2024 study in ‘Nature Aging’ validates p-tau217 blood biomarkers for forecasting Alzheimer’s symptoms within 3-4 years, enhancing early intervention and personalized medicine....
Recent studies reveal elevated IL-6 levels strongly correlate with Alzheimer’s and mild cognitive impairment, highlighting inflammaging’s role and potential for lifestyle and drug interven...
Recent neuroscience studies reveal that functional amyloids, regulated by chaperone proteins, are essential for long-term memory, challenging traditional views and offering new therapeutic avenues for...
